The regime involves two standard therapies alongside a powerful new hormone medication, darolutamide. The Daily Mail
See also:
- Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer (abstract) New England Journal of Medicine
Monday, 28 February 2022
Breakthrough triple treatment for prostate cancer offers patients years more healthy life
Breakthrough triple treatment for prostate cancer offers patients years more healthy life A breakthrough triple therapy for advanced prostate cancer can give patients years more healthy life and reduces the overall risk of death by a third.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment